Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1.

RSC Medicinal Chemistry
Ralph KirkAnthony Huxley

Abstract

The alarming reduction in drug effectiveness against bacterial infections has created an urgent need for the development of new antibacterial agents that circumvent bacterial resistance mechanisms. We report here a series of DNA gyrase and topoisomerase IV inhibitors that demonstrate potent activity against a range of Gram-positive and selected Gram-negative organisms, including clinically-relevant and drug-resistant strains. In part 1, we present a detailed structure activity relationship (SAR) analysis that led to the discovery of our previously disclosed compound, REDX05931, which has a minimum inhibitory concentration (MIC) of 0.06 μg mL-1 against fluoroquinolone-resistant Staphylococcus aureus. Although in vitro hERG and CYP inhibition precluded further development, it validates a rational design approach to address this urgent unmet medical need and provides a scaffold for further optimisation, which is presented in part 2.

References

Oct 30, 1992·Journal of Medicinal Chemistry·F SuzukiT Ohno
Aug 1, 1991·Antimicrobial Agents and Chemotherapy·H YoshidaS Nakamura
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·R K FlammS K Tanaka
Sep 1, 1996·The Journal of Antimicrobial Chemotherapy·S ConradW V Kern
Sep 23, 1997·Lancet·F M MacKenzieI M Gould
Mar 20, 2001·Current Pharmaceutical Design·V E Anderson, N Osheroff
Oct 8, 2008·Antimicrobial Agents and Chemotherapy·Sonia K Morgan-LinnellLynn Zechiedrich
May 5, 2010·Nature Reviews. Microbiology·Michael A KohanskiJames J Collins
Aug 6, 2010·Nature·Benjamin D BaxMichael N Gwynn
Aug 31, 2010·Nature Structural & Molecular Biology·Alexandre WohlkonigBenjamin D Bax
Jan 1, 2009·Microbial Biotechnology·Anna FàbregaJordi Vila
Apr 6, 2011·Antimicrobial Agents and Chemotherapy·Michael J PucciMilind Deshpande
Apr 21, 2012·Emerging Infectious Diseases·Daniel A TadessePatrick F McDermott
Sep 24, 2013·Diagnostic Microbiology and Infectious Disease·Felipe Lira de Sá CavalcantiTereza Cristina Leal-Balbino
Mar 1, 2014·Biochemistry·Katie J AldredNeil Osheroff
Jul 16, 2014·Bioorganic & Medicinal Chemistry Letters·Sheo B Singh
Apr 2, 2016·The Journal of Antimicrobial Chemotherapy·Victoria J SavageNeil R Stokes
Jun 22, 2016·Antimicrobial Agents and Chemotherapy·Victoria J SavageNeil R Stokes
Jul 28, 2016·Cold Spring Harbor Perspectives in Medicine·David C Hooper, George A Jacoby
Jul 14, 2019·Journal of Molecular Biology·Benjamin D BaxThomas Germe
Dec 6, 2019·MedChemComm·Thu D M PhamMark A T Blaskovich

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
NMR
column chromatography

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.